Marianne van den Bree
Overview
Explore the profile of Marianne van den Bree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gur R, Bearden C, Jacquemont S, Swillen A, van Amelsvoort T, van den Bree M, et al.
Mol Psychiatry
. 2024 Jul;
30(2):379-387.
PMID: 39048645
Rare recurrent copy number variants (CNVs) at chromosomal loci 22q11.2 and 16p11.2 are genetic disorders with lifespan risk for neuropsychiatric disorders. Microdeletions and duplications are associated with neurocognitive deficits, yet...
2.
Gur R, Bearden C, Jacquemont S, Jizi K, Amelsvoort van T, van den Bree M, et al.
Res Sq
. 2024 Jan;
PMID: 38234766
Rare recurrent copy number variants (CNVs) at chromosomal loci 22q11.2 and 16p11.2 are among the most common rare genetic disorders associated with significant risk for neuropsychiatric disorders across the lifespan....
3.
Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome
Ge R, Ching C, Bassett A, Kushan L, Antshel K, van Amelsvoort T, et al.
Hum Brain Mapp
. 2024 Jan;
45(1):e26553.
PMID: 38224541
22q11.2 deletion syndrome (22q11DS) is the most frequently occurring microdeletion in humans. It is associated with a significant impact on brain structure, including prominent reductions in gray matter volume (GMV),...
4.
Lin J, Zhao Y, Jabalameli M, Nguyen N, Mitra J, Swillen A, et al.
Mol Psychiatry
. 2023 Mar;
28(5):2071-2080.
PMID: 36869225
22q11.2 deletion is one of the strongest known genetic risk factors for schizophrenia. Recent whole-genome sequencing of schizophrenia cases and controls with this deletion provided an unprecedented opportunity to identify...
5.
Alsaqati M, Davis B, Wood J, Jones M, Jones L, Westwood A, et al.
Transl Psychiatry
. 2022 Oct;
12(1):438.
PMID: 36216811
Genetic evidence indicates disrupted epigenetic regulation as a major risk factor for psychiatric disorders, but the molecular mechanisms that drive this association remain to be determined. EHMT1 is an epigenetic...
6.
Egger J, Egger C, Woodcock K, de Witte L, van den Bree M, Van Dongen L, et al.
Front Psychiatry
. 2022 Sep;
13:1009376.
PMID: 36117652
No abstract available.
7.
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok A, McCutcheon R, et al.
Mol Psychiatry
. 2021 Jun;
28(5):2007.
PMID: 34158623
No abstract available.
8.
Rogdaki M, Devroye C, Ciampoli M, Veronese M, Ashok A, McCutcheon R, et al.
Mol Psychiatry
. 2021 May;
28(5):1995-2006.
PMID: 33981004
Dopaminergic dysregulation is one of the leading hypotheses for the pathoetiology underlying psychotic disorders such as schizophrenia. Molecular imaging studies have shown increased striatal dopamine synthesis capacity (DSC) in schizophrenia...
9.
Fiksinski A, Bearden C, Bassett A, Kahn R, Zinkstok J, Hooper S, et al.
Neuropsychopharmacology
. 2021 Mar;
47(7):1379-1386.
PMID: 33782512
Certain pathogenic genetic variants impact neurodevelopment and cause deviations from typical cognitive trajectories. Understanding variant-specific cognitive trajectories is clinically important for informed monitoring and identifying patients at risk for comorbid...
10.
Jones R, van den Bree M, Zammit S, Taylor P
J Interpers Violence
. 2020 Dec;
37(11-12):NP8559-NP8581.
PMID: 33283620
Alcohol consumption is known to have a disinhibiting effect and is associated with a higher likelihood of aggressive behavior, especially among men. People with certain personality traits maybe more likely...